Product
MY-586
1 clinical trial
2 indications
Indication
COVID-19Indication
PreventionClinical trial
A Randomized, Double-blind, Placebo-parallel Controlled Clinical Study to Evaluate the Safety and Tolerability of MY-586 SARS-CoV-2 Neutralizing Antibody Nasal Spray in Healthy SubjectsStatus: Recruiting, Estimated PCD: 2023-12-30